Abstract
INTRODUCTION
Chronic pain is the most common symptom that brings a patient to the physician. Currently available analgesic drugs such as opiates and non-steroidal anti-inflammatory drug (NSAID) are not fully accepted due to their adverse effects. For example, opioids may induce physical dependence, tolerance and other side effects including respiratory depression, drowsiness, nausea, constipation and alterations of endocrine and autonomic nervous system activities. Also NSAIDs can aggravate peptic ulcers and cause hepatorenal complications. Consequently, there is renewed interest in new natural analgesics, especially of plant origin [1, 2] .
Inflammation plays role in the mechanism of pain. It can decrease pain threshold, increase nociceptive neuron firing rate and facilitate pain transmission; these processes can augment pain [3, 4] . On the other hand, the process of inflammation is necessary for healing of damaged tissues. In response to inflammation, a variety of innate immune cells such macrophages can be activated. However, uncontrolled inflammation induces tissue injury. Cytokine production is a primary step of the reaction of macrophages to inflammatory stimuli [5] . During inflammation, the over-production of inflammatory cytokines such as TNF-α, IL-6 and IL-1 by activated macrophages is a crucial event for triggering progressive stimulation of immune cells [6] .
One of the plants said to have immunomodulatory and anti-inflammatory effects is Scrophularia megalantha Boiss (Scrophulariaceae) [7, 8] . Several species of this genus have been used since ancient times as folk remedies for ailments such as inflammatory diseases, scabies, eczema, psoriasis, tumors, etc. In addition, we have previously demonstrated the inhibitory effect of Scrophularia striata extract on nitric oxide production using in vitro and ex vivo models [7] . Some species in this genus have shown anti-inflammatory activity [8] . Therefore, the objective of the present study was to investigate the effect of the ethanol extract of the aerial parts of Scrophularia megalantha on proinflammatory cytokines, including TNF-α and IL-6 denerated by LPS-stimulated macrophages, and formalin-induced inflammatory pain in male rats.
EXPERIMENTAL Plant material and preparation of extract
The aerial parts of Scrophularia megalantha were collected from Kelardasht Region (Mazandaran Province) in the northern part of Iran, in May 2011 and air-dried at room temperature. The plant was identified by Mr. Ajani of the Department of Botany, Institute of Medicinal Plants (IMP) of Karaj, Iran. A voucher specimen (no. 1461) was deposited in the herbarium of the institute. The plant material was dried, powdered, and 100 g macerated with 80 % ethanol (900 ml) for 3 days with three changes of the solvent. The resulting extract was filtered and evaporated under vacuum to a dry powder (yield, 12.1 %). The plant extract was dissolved in dimethylsulfoxide (DMSO) to contain 0.1 %w/v of the extract and used at appropriate concentrations.
Phytochemical assay
In order to recognize chemical components of the extract, thin layer chromatography (TLC) was 
Formalin test in rats
Analgesic activity was performed using formalin test as described by Dubuisson and Dennis [9] . Briefly, the rats were divided into 6 groups, each consisting of seven rats. The rats were moved to the test room 1 h before the experiment and acclimatized for 30 min in an acrylic observation chamber (30 cm in diameter and height) prior to intraperitoneal administration of the extract (25, 50,100 and 200 mg/kg) or diclofenac-Na (5 mg/kg) or normal saline (1 ml), Thirty minutes later, 50 μL of 2 % formalin was injected subcutaneously into the plantar surface of the right hind paw with a 30-gauge needle. Each rat was then immediately returned to the observation chamber, and pain behavior recorded. Pain behavior was scored (at 1-min interval for 60 min) as follows: 0, the injected paw was not favored; 1, the injected paw had little or no weight placed on it; 2, the injected paw was elevated and not in contact with any surface; and 3, the injected paw was licked or bit. The behavioral response of each rat during the early phase (1 -7 min) and the late phase (15 -60 min) was separately evaluated [9] .
Isolation of peritoneal macrophages from rats
The rats were killed by cervical dislocation and peritoneal macrophages were harvested immediately by lavaging with ice cold sterile phosphate buffer saline (PBS). The cells were washed twice and plated in RPMI 1640 medium (Sigma Chemical Co) containing 10 % fetal bovine serum (Gibco), 100 U/ml penicillin and 100 µg/ ml streptomycin (Sigma Chemical Co), and incubated for 2 h at 37 °C in 5 % CO 2 humidified incubator. Non-adherent cells were removed by gently washing with PBS and freshly prepared medium was added. Cell viability was checked by trypan blue exclusion technique. An aliquot of the cell suspension was mixed with an equal volume of 0.4 %w/v trypan blue in PBS and incubated for 10 min. The viability of the macrophages was > 98 %.
Measurement of pro-inflammatory cytokines

LPS
(1 µg/ml) stimulated peritoneal macrophages were co-incubated with extract (10 - 
Statistical analysis
Data are presented as mean ± standard deviation (SD). Statistical analyses were performed by one-way analysis of variance (ANOVA) to express difference among the groups followed by Bonferroni post hoc test. All analyses were performed using SPSS software, version 16. Differences were considered statistically significant at p < 0.05.
RESULTS
Chemical components of the extract
Phytochemical assay by thin layer chromatography showed the presence of phenolic compounds, flavonoids and phenyl propanoids in S. megalantha extract.
S. megalantha extract reduced pain symptoms
Both acute (early) and chronic (late) phases of pain were observed in all groups after formalin injection (Fig 1) .
In the acute phase, the extract decreased dosedependently pain symptoms in comparison to control that was significant at 100 and 200 mg/kg dose (p < 0.05, p < 0.01) as shown in Fig 2A. The positive control, diclofenac-Na (5 mg/kg), significantly inhibited formalin-induced pain in the late phase (p < 0.01) ( Fig 2B) ; however, there was no inhibition in the early phase (Fig 2A) .
The extract significantly inhibited the late phase of formalin-induced pain, compared with control ( Fig 2B) . The inhibitory effect of extract (100 and 200 mg/kg) was stronger than that of the positive control, diclofenac-Na (5 mg/kg) (p < 0.001). 
S. megalantha extract reduced LPSstimulated proinflammatory cytokines production in peritoneal macrophages
The effect of co-culture of LPS and extract for 24 h on the release of TNF-α and IL-6 proinflammatory cytokines into the medium is shown in Figs 3 and 4 . Rat macrophages responded strongly to the addition of LPS by releasing TNF-α and IL-6 into the supernatant medium. Treatment of the cells with S. megalantha extract attenuated, in a concentration-dependent manner, the production of both pro-inflammatory cytokines by macrophages. The extract 
DISCUSSION
S. megalantha is an important genus consisting of about 60 species in the Iran [10] . Most species belonging to Scrophularia genus have been used for anti-inflammatory therapy in folk medicine. A pervious study showed that some spices of Scrophularia have various flavonoids with antiinflammatory properties; this study also indicates that S. megalantha extract contains flavonoids [11] .
Phenylpropanoids play multiple important biologic roles, for example, anti-inflammatory action by reducing pro-inflammatory stimuli [12] . On the other hand, several reviews have reported the anti-inflammatory activity of phenols, attributing their properties not only to antioxidant capacity, but also to pro-inflammatory mediator modulation [13] . Our results show that phenolic compounds, flavonoids and phenyl propanoids are present in S. megalantha extract. Therefore, it is probable that the extract would exert analgesic and anti-inflammatory actions. The present results indicate that the ethanol extract of S. megalantha reduced symptoms of pain dose-dependently in both acute and chronic pain phases. This suggests that the extract exerts its analgesic action by both peripheral and central mechanisms. When formalin is injected into the footpad of an animal, it produces two phases of nociceptive behavior that are separated by a short period of quiescence in which there is no apparent pain. The first or acute phase typically occurs in the first 5 min while the second starts from 15 min and lasts about 40 -60 min after injection. The early phase seems to be caused mainly by direct activation of both low-threshold mechanoreceptors and nociceptive primary afferent fibers due to peripheral stimulus. The late phase, also called the tonic phase, appears to be dependent on the combination of inflammatory reaction in the peripheral tissue and functional changes at some level of the central nervous system, spatially in the dorsal horn of the spinal cord, generally called central mechanisms [14] .
In the present study, we observed more intense analgesic effect on the late (inflammatory) phase in the formalin test and the results show that the extract has potent analgesic effect. Therefore, it contains compounds that act peripherally and reduce inflammation [15] . In addition, our results indicate that the anti-nociceptive effect of the extract may be due to its anti-inflammatory effect. Pro-inflammatory cytokines, such as interleukin-6 (IL-6), is a cytokine initially indentified as T-cell derived factor regulating B-cell growth and differentiation. Furthermore, deregulation of IL-6 production has been implicated in a variety of inflammatory diseases [16] . Pro-inflammatory cytokines such as IL-1 and tumor necrosis factor-α (TNF-α) markedly stimulate IL-6 production [17] . These mediators are able to recruit leukocytes, such as neutrophils, as reported for several experimental models [18, 19] . In the present study, the levels of TNF-α and IL-6 were significantly decreased when treated with the extract. Thus, a putative anti-inflammatory mechanism could be associated with the degree of inhibition of pro-inflammatory mediators, such as TNF-α and IL-6. Our results indicate that the extract exhibited antinociceptive and antiinflammatory activities. Although the antiinflammatory mechanisms of S.megalantha are likely linked to the decrease in IL-6 and TNF-α pro-inflammatory cytokines, the effect of the extract on other inflammatory mediators is also essential.
CONCLUSION
Based on the findings of the present study, the ethanol extract of S. megalantha possesses analgesic and anti-inflammatory potentials. However, further studies are necessary to determine precisely the underlying mechanisms of these actions as well as to isolate the active compound(s) responsible for the activities.
